For people living with severe and recurring heart rhythm problems, treatment options are often limited and carry high risks. Over the past few years, doctors and researchers have been exploring a new option: stereotactic arrhythmia radiation therapy (STAR). The results showed that radiation therapy was just as effective as ablation in controlling arrhythmia but carried far fewer immediate risks. After one year, 73% of radiation patients were still alive compared to 58% of ablation patients; at three years, survival was equal at 45% for both groups. Radiation therapy could one day mean fewer invasive procedures, fewer hospitalizations, and a safer path to stabilizing one of the most dangerous heart rhythm disorders.